History of the development of investigations URODYNAMICS
The term "urodynamics" encompasses any investigation of urinary tract function although it is often used colloquially as a synonym for cystometry. Cystometry, the measurement of bladder pressure, has been the main tool used to show abnormal behaviour of the neurogenic bladder.
The earliest reference to a study measuring bladder pressure is commonly given as the paper by Mosso and Pellacani published in 1882.1 With a water manometer they showed that bladder pressure rose at the start of micturition and then gradually declined but that during storage the pressure measured within the organ gave little indication of what volume it contained. However, the paper This combination provides a complete picture of the behaviour of the bladder both during filling and emptying although it is expensive and exposes the patient to x rays. Much can be learnt from simple cystometry alone and it is this investigation which is now a standard facility in almost every district general hospital with a urology department.
The hydrodynamic problems of measuring fluid flow are different from measuring pressure within an organ. Introduction of simple and cheap equipment for measuring urinary flow rate' has led to this becoming routine; combined with ultrasound measurement of the postmicturition residual volume, it provides a simple non-invasive means 
UROFLOWMETRY
Uroflowmetry is the measurement of urinary flow rate. This is a non-invasive investigation. The patient presents with a full bladder and voids into a receptacle in the base of which is a spinning wheel. Urinary flow slows the rate of rotation and from this a graphical output of flow rate can be obtained (fig 4) .
Abnormalities of flow can be due to local urological problems such as prostatic hypertrophy, a urethral stricture, or neurogenic disorders of the bladder outlet mechanism. Detrusor sphincter dyssynergia, which occurs with spinal cord disease, is a common example of this and results in interrupted flow (fig 5) . Uroflowmetry combined with ultrasound scanning of the postmicturition residual volume is used as a screening test to exclude seri- Figure 4 Uroflowmetry. The lower trace shows the rate of urinaryflow, which reaches a maximum of 40 mlls in three seconds and then declines. The upper trace is the result of integrating the flow rate and shows that a total of 275 ml was passed. 
Recording the pudendal evoked potential is similar to recording tibial evoked potentials. The same cortical recording electrodes can be used and it is advisable to record the tibial evoked responses first to familiarise the patient with the technique. The patient is then asked to hold the stimulating electrode on the dorsal nerve of the penis or clitoris and a similar number of stimuli as needed for obtaining the tibial evoked potentials are given. Surprisingly the latency of tibial and pudendal responses is similar despite the difference in conduction distance. This is thought to be due to the slower conduction velocity of the pudendal afferents compared with fast conducting muscle afferents which respond when the tibial nerve at the ankle is stimulated. 22 The introduction of a method to record the pudendal evoked potential was initially hailed as promising.23 It was considered that this would provide a means of testing the afferent innervation from the sacral region and certainly the responses were delayed in patients with conditions such as multiple sclerosis.2426 Like the lower limb somatosensory evoked potentials, the pudendal evoked potential is delayed if there is spinal cord disease but this is also usually apparent on clinical examination. Recent studies have shown that the pudendal evoked potential is very rarely abnormal unless there are other clinical signs of neurological disease27-29 and furthermore if the lesion is predominantly unilateral the pudendal evoked potential can be within normal limits.29 It seems that there is little diagnostic gain in recording the pudendal evoked potential although it is sometimes reassuring to show that it is normal in patients in whom neurological problems are suspected.
A technique for measurement of the terminal motor latency of the pudendal and perineal nerves (PTML) was devised at St Mark's Hospital. 30 It has been used to show pathophysiological changes in these nerves in women with faecal,30 urinary,3 or double incontinence. 32 The pudendal nerve is stimulated transrectally near the ischial spine through the wall of the rectum using an electrode mounted on the tip of the examiner's finger. An electrode is mounted at the base of the finger, which records from the anal sphincter, and a ring electrode mounted on a Foley catheter can be used to record from the periurethral striated muscle. The latency of the response has been found to be prolonged in women with urinary stress incontinence after childbirth and women with faecal incontinence due to sphincter weakness. It is thought that stretching of the nerves during parturition and also with straining at defaecation in chronic Unfortunately no specific treatment has yet been effective and the women manage best by performing intermittent self catheterisation. A similar abnormality has not been found in men and extensive neurophysiological testing has failed to show a defect in the less commonly encountered young men with urinary retention without a urological explanation. The role of primary detrusor abnormality in these men needs to be explored as it does in patients with idiopathic detrusor instability. Unfortunately there is as yet no neurophysiological means of investigating detrusor smooth muscle function.
Planning investigations
Investigations of bladder symptoms are carried out for two very different purposes: with bladder symptoms and established neurological disease urodynamic investigations may be performed to try and understand the pathophysiological basis for the patient's symptoms and obtain information on which to base recommendations for management of incontinence.
When the question is being asked "is this a neurogenic bladder?" a different approach is required. In this instance investigations are of a neurological or neurophysiological nature.
URODYNAMIC INVESTIGATIONS IN PATIENTS WITH ESTABLISHED NEUROLOGICAL DISEASE
Poor bladder control is a common and troublesome feature of many types of neurological disease, especially of the spinal cord. The commonest complaints are of urgency, frequency, and urge incontinence and in established neurological disease these can be assumed to reflect detrusor hyperreflexia. However, patients with neurogenic bladder disorders often have a disorder of emptying as well; incomplete emptying is probably due to a combination of detrusor sphincter dyssynergia and poorly sustained detrusor contractions. If the bladder does not empty completely the persistent postmicturition residual volume acts as a stimulus for repeated detrusor contractions so that efforts to treat detrusor hyperreflexia are unlikely to succeed until effective emptying is achieved. The most effective treatment for detrusor hyperreflexia is an anticholinergic drug (oxybutynin is currently recommended) but there is no oral medication which improves neurogenic voiding disorders and the best management is intermittent catheterisation, performed by the patient or carer.
In summary the presence of detrusor hyperreflexia may be reliably deduced from clinical history, but incomplete emptying, although contributing appreciably to the problem, can be largely asymptomatic. For this reason the single most important investigation when planning the management of patients with neurogenic incontinence is measurement of the postmicturition residual volume. This can either be done by simple ultrasound (see earlier) or by "in-out" catheterisation. The advantage of using catheterisation is that it familiarises the patient with what is involved in intermittent self catheterisation.
Investigation of the postmicturition residual volume is recommended before starting on an anticholinergic drug, as shown in the algorithm in fig 6. A further point about treatment with anticholinergic drugs is that although they may be effective in lessening detrusor hyperreflexia they can adversely affect bladder emptying. It 
Conclusion
The difficulty that neurologists have had with investigating the neurogenic bladder stems from a combination of factors: the range of presenting symptoms is limited to either incontinence or retention, it is not possible to examine the bladder clinically, and the impression that urodynamics may prove a "diagnosis" has obscured the fact that there are many bladder disorders of unknown cause. Finally there has been the neurologists' reluctance to become involved in the management of incontinence.
In bladder dysfunction established neurological disease should be regarded as an essentially neurological symptom and investigated and managed appropriately. Bladder symptoms are among the most treatable of neurological deficits and are an unpleasant and troublesome burden for the patient and their carer.
In patients sent from urologists to neurologists the emphasis should be on excluding spinal cord disease, which can be readily done by clinical examination. A high index of suspicion for multiple system atrophy should be maintained for older patients as this is a neurological disease which can present with bladder dysfunction and the patients do not benefit from urological surgery.
